Investment Analysts’ Upgrades for August, 15th (DPSGY, FLS, HOLI, RSPP, RVNC, RXDX, SDLP, SENS, SLFPF, SMED)

Investment Analysts’ upgrades for Tuesday, August 15th:

Deutsche Post AG (OTCMKTS:DPSGY) was upgraded by analysts at Jefferies Group LLC from a hold rating to a buy rating.

Flowserve Corporation (NYSE:FLS) was upgraded by analysts at Susquehanna Bancshares Inc from a neutral rating to a positive rating.

Hollysys Automation Technologies (NASDAQ:HOLI) was upgraded by analysts at J P Morgan Chase & Co from a neutral rating to an overweight rating.

RSP Permian (NYSE:RSPP) was upgraded by analysts at Zacks Investment Research from a strong sell rating to a hold rating. According to Zacks, “RSP Permian, Inc. is engaged in the acquisition, exploration, development and production of unconventional oil and associated liquids-rich natural gas reserves primarily in the Permian Basin of West Texas. RSP Permian, Inc. is based in Dallas, United States. “

Revance Therapeutics (NASDAQ:RVNC) was upgraded by analysts at Zacks Investment Research from a hold rating to a buy rating. Zacks Investment Research currently has $26.00 price target on the stock. According to Zacks, “Revance is a Silicon Valley-based biotechnology company. The company is developing a portfolio of products for aesthetic medicine and underserved therapeutic specialties, including dermatology and neurology. Revance’s science is based upon a proprietary TransMTS® peptide technology, which when combined with active drug molecules, may help address current unmet needs. Revance’s initial focus is on developing daxibotulinumtoxinA, the company’s highly purified botulinum toxin, for a broad spectrum of aesthetic and therapeutic indications, including facial wrinkles and muscle movement disorders. The company’s lead drug candidate, DaxibotulinumtoxinA for Injection (RT002), is currently in development for the treatment of glabellar lines and cervical dystonia and has the potential to be the first long-acting neurotoxin. The company holds worldwide rights for all indications of RT002 injectable and RT001 topical and the pharmaceutical uses of the TransMTS technology platform. “

Ignyta (NASDAQ:RXDX) was upgraded by analysts at Zacks Investment Research from a sell rating to a hold rating. According to Zacks, “Ignyta, Inc. is a biotechnology company. It develops precision medicine with integrated Rx/Dx solutions for cancer patients. The company focuses on the development of RXDX-101, its proprietary oral tyrosine kinase inhibitor that targets solid tumor indications, and advancing its novel Spark discovery programs that leverage its proprietary cancer genomic and epigenomic knowledge bases. Ignyta, Inc. is based in San Diego, California. “

Seadrill Partners (NASDAQ:SDLP) was upgraded by analysts at Zacks Investment Research from a hold rating to a buy rating. They currently have $3.00 target price on the stock. According to Zacks, “Seadrill Partners LLC is engaged in owning, operating and acquiring offshore drilling rigs. The Company’s drilling rigs are under long-term contracts with major oil companies. Seadrill Partners LLC is based in London, United Kingdom. “

Senseonics Holdings (NASDAQ:SENS) was upgraded by analysts at Zacks Investment Research from a sell rating to a hold rating. According to Zacks, “Senseonics Holdings, Inc. is a medical technology company which focused on the design, development and commercialization of glucose monitoring systems. Senseonics Holdings, Inc. is based in Germantown, United States. “

Standard Life (OTC:SLFPF) was upgraded by analysts at Barclays PLC from an underweight rating to an overweight rating.

Sharps Compliance Corp (NASDAQ:SMED) was upgraded by analysts at Zacks Investment Research from a hold rating to a strong-buy rating. The firm currently has $6.25 price target on the stock. According to Zacks, “Headquartered in Houston, Texas, SHARPS COMPLIANCE is a leading provider of cost-effective disposal solutions for small quantity generators of medical waste. The Company’s flagship product, the Sharps Disposal by Mail System, is a cost-effective and easy-to-use solution to dispose of medical waste such as hypodermic needles, lancets and any other medical device or objects used to puncture or lacerate the skin. The Company also offers a number of products specifically designed for the home healthcare market. Sharps Compliance focuses on targeted growth markets such as the pharmaceutical, retail, healthcare, commercial, professional and hospitality markets, as well as serving a variety of additional markets. Sharps is a leading proponent and participant in the development of public awareness and solutions for the safe disposal of needles, syringes and other sharps in the community setting. “

SPDR MSCI Europe Energy UCITS ETF (NYSE:STN) (TSE:STN) was upgraded by analysts at Zacks Investment Research from a hold rating to a buy rating. They currently have $30.00 price target on the stock. According to Zacks, “Stantec Inc. provides professional consulting services in planning, engineering, architecture, interior design, landscape architecture, surveying and geomatics. It also provides professional consulting services in environmental sciences, project management, and project economics for infrastructure and facilities projects. Its services include, or relate to, the development of conceptual plans, zoning approval of design infrastructure, transportation planning, traffic engineering, landscape architecture, urban planning, design construction review and surveying. It provides knowledge-based solutions for infrastructure and facilities projects through value-added professional services principally under fee-for-service agreements with clients. Stantec Inc. is headquartered in Edmonton, Canada. “

Southcross Energy Partners, L.P. (NYSE:SXE) was upgraded by analysts at Zacks Investment Research from a hold rating to a buy rating. The firm currently has $2.50 price target on the stock. According to Zacks, “Southcross Energy, LLC provides natural gas gathering, processing, treating, compression and transportation services and NGL fractionation and transportation services. It also sources, purchases, transports and sells natural gas and NGLs to its power generation, industrial and utility customers. The Company’s services include connecting producing wells to pipeline gathering systems; processes and treats gas for pipeline transportation and commercial use; transports gas to end-users and pipeline interconnects; and purchase and sale of gas. Its assets are located in South Texas, Mississippi and Alabama. Southcross Energy, LLC is based in Dallas, Texas. “

TransAlta Corporation (NYSE:TAC) (TSE:TA) was upgraded by analysts at Zacks Investment Research from a hold rating to a buy rating. They currently have $7.00 price target on the stock. According to Zacks, “TransAlta is Canada’s largest non-regulated electric generation and marketing company. “

Yara International ASA (OTCMKTS:YARIY) was upgraded by analysts at DNB Markets from a sell rating to a hold rating.